Guillaume Seret, Catherine Hanrotel-Saliou, Boutahar Bendaoud, Yannick Le Meur, Yves Renaudineau. Homozygous FCGR3A-158F mutation is associated with delayed B-cell depletion following rituximab but with preserved efficacy in a patient with refractory lupus nephri.
Clinical Kidney Journal, Oxford University Press, 2013, 6 (1), pp.74-76.
⟨10.1093/ckj/sfs162⟩.
⟨hal-00827682⟩